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Central Odontogenic Fibroma is a benign neoplasm of mesenchymal origin that makes up less than 5% of odonto-
genic tumors. There is a variation of this lesion that includes a zone of giant cells. This neoplasm is characterized by 
fibroblast proliferation, a component of apparently inactive odontogenic epithelium within a mature connective tis-
sue stroma and multinucleated osteoclast-like giant cells. Clinically, it manifests as a slow-growing central lesion, 
which causes painless cortical expansion and may occasionally cause the displacement of adjacent dental organs or 
resorption. We present a new case of this combined lesion that was revealed radiographically as a well-defined ra-
diolucent area in the left mandibular body. Histologically, we identified a mesenchymal lesion composed of mature 
fibrocellular tissue, where islands and cords of odontogenic epithelium and fibrocellular areas with numerous giant 
cells can be distinguished. The immunohistochemical examination was positive for giant cells with the marker 
CD68 and positive for epithelium cords with the marker CK19, which indicates that this  an odontogenic lesion.
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Introduction
Central Odontogenic Fibroma (COF) is a benign neo-
plasm of mesenchymal origin. It is uncommon, accoun-
ting for less than 5% of odontogenic tumors. In an even 
lower percentage of cases, there is a variant consisting 
of an area of central giant cell granuloma (CGCG). This 
subtype is formed histologically by fibroblast prolife-
ration and a variable component of apparently inacti-
ve odontogenic epithelium, scattered within a mature 
connective tissue stroma where some lesions may show 
osteoid deposits (1). Clinically, it manifests as a slow-
growing central lesion, which causes painless cortical 
expansion and may occasionally cause the displacement 
of adjacent dental organs or resorption (2). Radiogra-
phically, it is revealed as a unilocular or multilocular, 
well-defined and radiolucent area (3). It may occur in 
the maxilla or the mandible; when found in the maxilla, 
it predominates in the anterior region of the first molar, 
and when in the mandible, it appears more frequently in 
the molar region (4). The frequency of reported cases 
to date has shown a higher percentage of occurrence in 
young women (1-3). There are three pathogenic hypo-
theses based on the clinical and pathological characteris-
tics. The first considers the neoplasm to be a COF with 
reactive CGCG component; the second proposes that it 
is a hybrid lesion; and the third supposes a collision of 
the COF/CGCG (2-4). The treatment is surgical removal 
of the lesion, by curettage of the surrounding area. After 
its removal, a well-defined but non-encapsulated speci-
men is obtained, which is irregular, soft and brown. It 
has a rough surface containing small fragments of hard 
tissue. Recurrences of these lesions are common (25%) 
(3).
The purpose of this article is threefold. First, to report a 
case of a hybrid neoplasm, secondly to list the clinical, 
radiological and histological characteristics and thirdly 
to compare the results found in this neoplasm with other 
hybrid tumors previously reported.     
Case Report
A 14-year-old male patient was afflicted with a mild vo-
lume increase in the left mandibular body that had deve-
loped over six months. The patient was asymptomatic, 
with no tooth displacement or resorption, firm palpa-
tion, normal characteristics in the adjacent mucosa, and 
a clinical history with no record of notable trauma or 
pathological antecedents. The panoramic radiograph re-
vealed a well-defined unilocular radiolucent area in the 
body of the mandible, located below the area between 
the first premolar and left second molar (Fig 1a). Com-
puted Axial Tomography (CAT) revealed a multilocular 
lesion with a vestibular cortical expansion (Figure 1b). 
An incisional biopsy was performed with a correspon-
ding histopathological study that identified a mesenchy-
mal lesion composed of mature fibrocellular tissue. In 
this study, islands and strands of odontogenic epithelium 
and fibrocellular areas with numerous multinucleated 
giant cells can be distinguished (Fig 2a, 2b). An immu-
nohistochemical technique was performed, which tested 
positive for giant cells with the marker CD68 (Fig 3a) 
and positive for islands and strands of odontogenic epi-
thelium with the marker CK19 (Fig 3b), thus corrobo-
rating the combined strain of the lesion. Subsequently, 
we carried out a resection of the lesion and installed a 
Krenkel dynamic reconstruction plate. Findings: We ob-
tained a defined but non-encapsulated specimen that was 
soft, brown, irregularly shaped, and had a rough surface 
with small fragments of hard tissue. At the surgical site, 
cortical expansion as well injury of the basal edge was 
found. Curettage was performed in the area with milling 
of the bone walls. 
In the 2-year postoperative control, we observed facial 
symmetry, bone regeneration beginning at the perios-
teum, as well as an occlusion and alveolar ridge appro-
priate for future rehabilitation with dental implants, thus 
preserving the function and aesthetics of the patient’s 
facial structure.
The clinical and histological characteristics of this com-
Fig. 1. Imagenology:  a)Panoramic radiography reveals a unilobular 
lesion between the first premolar and left lower second molar,  b)
Computerized Axial Tomography showing a multilocular lesion with 
vestibular cortical expansion
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(4,8). 
CK19 is an intermediate filament protein responsible for 
the structural integrity of epithelial cells. During fetal 
development, it is expressed in all epithelial cells from 
the mesenchyme, and high positivity in the odontogenic 
epithelium has been reported (7). CD68 is a glycoprotein 
expressed on the plasma membrane of macrophages and 
monocytes. It is used to qualitatively identify, by optical 
microscopy, macrophage/monocyte lineage cells in nor-
mal and neoplastic tissues and is highly positive in mul-
tinucleated giant cells (8), hence the usefulness of using 
these two markers in this type of combined lesion.
The use of this immunohisotchemical markers are nee-
ded to understand these types of lesions, however the 
use of hematoxilin and eosin is enough to realize the 
histopathology diagnosis of this kind of tumors. 
There are three hypothesis that intend to explain the na-
ture of this combined lesions, the first one suggest the 
possibility that this lesion can be a collision tumor, this 
happens when two lesions are present in a synchronous 
way and can or cannot be mixed, or can both or just one 
of them be extremely small.  The second hypothesis ha-
bination of Central Odontogenic Fibroma with Giant 
Cells require a detailed differential diagnosis.
The differential diagnosis that are considered to identi-
fy COF with similar lesions among them for example: 
mixoma, fibromixoma and a desmoplastic fibroma (4-6). 
Conversely, the differential diagnosis that includes giant 
cells lesions, can be considered cherubim, brown tumor 
of hyperparathyroidism and aneurismal bone cyst (7). 
This components can be fully identified, which is why 
the indicators CK19 and CD68 were used in the immu-
nohistochemical study.
Discussion
From 1992 until 2008 there has been 13 COF reported 
cases with CGCG (4,8,9). Histologically these lesions 
present a wide range that goes from dense to delicate 
collagen with  fibromixoid stroma and odontogenic epi-
thelial bands that seem inactive, may seen hyaline whi-
te corpuscle, fusiform cells and intra osseous lesions 
mainly formed of fibro cellular tissue with multiple he-
morrhagic focus, giant multinuclear  cells added  and in 
some cases immature bone formation  can be observed 
Fig. 2. Histophatology: a) Microphotography showing a giant cells 
(red circle) and the odontogenic epithelium (arrows), (100x).b) 
Incisional biopsy showing a mature fibrocellular area in which is-
lands and cords of odontogenic epithelium are mixed with numerous 
multinucleated giant cells in some areas. 
Fig. 3.  Immunohistochemistry: a)Positive staining for marker CD68 
in giant cells. (400X), b) Red arrow show a positive staining for mar-
ker CK19 in islands and strands of odontogenic epithelium. Yellow 
arrows show giant cells. (400x).
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ppens when is suggested that the COF generates a reacti-
ve response due to the presence of inactive odontogenic 
epithelium. This theory in turn suggest that a makeup 
giant cellular response whose cells present affinity for 
inactive odontogenic epithelium; histologically shows 
COF characteristics and giants cells present in periphe-
ral zone.  The third proposal suggest that growth factors 
are produced by a primary CGCG lesion that produces 
the proliferation of odontogenic epithelium and the for-
mation of secondary COF posterior (4,7-9).    
The cases reported so far show different proportions 
in the components of the lesion. Mosqueda et al.(4) 
and Allen et al. (8) report a greater number of cellular 
components for central odontogenic fibroma, including 
fibroblasts and epithelial areas. This fact points to the 
idea of an odontogenic tumor with a component of reac-
tive giant cells. Moreover, Odell et al. (10) say that the 
clinical features of this lesion, such as age distribution, 
a higher incidence in females, a  predominance in the 
mandibular region, and cortical expansion, make it look 
more like central giant cell granuloma. However, these 
clinical manifestations are also associated with central 
odontogenic fibroma when present in the mouthpiece 
(2); therefore, it cannot be established that this lesion 
stems from central giant cell granuloma. 
It is noteworthy that the presence of multinucleated os-
teoclast-like giant cells scattered throughout the fibroce-
llular tissue, present in other lesions, such as cherubism, 
aneurismal bone cysts, brown tumors from hyperpara-
thyroidism and some other less common bone tumors, in 
addition to a greater number of elements of central odon-
togenic fibroma in this combined neoplasia, supports the 
idea that the giant cell component is caused by a reaction 
to a stimulus that cannot yet be identified, making it ne-
cessary to consider this point in future research.
References
Rania H, Mark A. Hybrid Central Odontogenic Fibroma with Giant 1. 
Cell Granuloma-like Component: Case Report and Review of Lite-
rature. Head Neck Pathol. 2002;2:222-6
Tosios KI, Gopalakrishnan R, Koutlas IG. So-called hybrid central 2. 
odontogenic fibroma/central giant cell lesion of the jaws. A report 
on seven additional cases, including an example in a patient with 
cherubism, and hypotheses on the pathogenesis. Head Neck Pathol. 
2008;2:333-8.  
Kaplan I, Manor I, Yahalom R, Hirshberg A. Central giant cell 3. 
granuloma associated with central ossifying fibroma of the jaws: 
a clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod. 2007;103:e35-41.
Kaffe I,  Buchner A. Radiologic features of central odontogenic 4. 
fibroma. Oral Surg Oral Med Oral Pathol. 1994; 78: 811-8. 
Mosqueda Taylor A, Bermudez Flores V, Diaz Franco M. Com-5. 
bined central odontogenic fibroma and giant cell granuloma- like 
lesion of the mandible: report of a case and review of the literature. 
J Oral Maxillofac Surg. 1999;57:1258–2.
Brannon RB. Central odontogenic fibroma, myxoma (odontogenic 6. 
myxoma, fibromyxoma), and central odontogenic granular cell tu-
mor. Oral Maxillofac Surg Clin North Am. 2004;16:359–7
Ikeshima A, Utsunomiya T. Case report of intraosseous fibroma: a 7. 
study on odontogenic and desmoplastic fibromas with a review of 
the literature. J oral Sci. 2005;47:149–57
Regezi JA. Odontogenic cysts, odontogenic tumors, fibroosseous, 8. 
and giant cell lesions of the jaws. Mod Pathol. 2002;15:331–41
Allen CM, Hammond HL, Stimson PG. Central odontogenic fibro-9. 
ma, WHO type. A report of three cases with an unusual associated 
giant cell reaction. Oral Surg Oral Med Oral Pathol. 1992;73:62–6
Odell EW, Lombardi T, Barrett AW, Morgan PR, Speight PM. Hy-10. 
brid central giant cell granuloma and central odontogenic fibroma-
like lesions of the jaws. Histopathology. 1997;30:165-71.
